Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
This update summarizes the completion of a clinical trial evaluating illness-related distress in women with clinically localized cutaneous m…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma [Phase 1]
This document reports the completion of a Phase 1 trial evaluating intratumoral injections of INXN-3001 in patients with stage III or IV mel…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg [Phase 3]
A Phase 3 trial comparing melphalan with versus without tumor necrosis factor for locally advanced melanoma of the arm or leg has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Dose Escalation Study of MLN4924 in Adults With Melanoma [Phase 1]
Clinical trial update for a Phase 1 dose-escalation study of MLN4924 (pevonedistat) in adults with metastatic melanoma.
-
FDA approval · 2013-07-03FDA Approved: ZELBORAF — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Zelboraf (vemurafenib) from Genentech, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies [Phase 1]
Phase 1 study of TAK-733 in adults with advanced nonhematologic malignancies has completed enrollment.
-
EMA approval · 2013-06-28European Medicines Agency recommends approval of Tafinlar for the treatment of metastatic melanoma
EMA recommends approval of Tafinlar (dabrafenib) for treating metastatic melanoma, indicating regulatory support for its use in this indicat…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Boron Neutron Capture Therapy in Treating Patients With Melanoma [Phase 2]
A Phase 2 clinical trial evaluating boron neutron capture therapy for melanoma (skin cancer) has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma [Phase 2]
A Phase 2 clinical trial evaluating indomethacin in combination with a biological therapy for advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
The document reports completion of a Phase 1 clinical trial evaluating a vaccine therapy in patients with metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating vaccine therapy with high-dose interleukin-2 in metastatic melanoma has completed. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy for stage III or stage IV melanoma has completed enrollment and provides an updat…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma [Phase 2]
A Phase 2 trial evaluating a vaccine therapy with immune adjuvants for advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes [Phase 3]
Phase 3 trial comparing immediate radiotherapy after surgery to observation for melanoma involving regional lymph nodes. The study status is…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a vaccine therapy for patients with stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating interferon alfa plus thalidomide in stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 clinical trial evaluating vaccine therapy and monoclonal antibody therapy for stage IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma [Phase 2]
This document updates a Phase 2 trial of a vaccine therapy for recurrent or refractory metastatic melanoma, with the study status listed as …
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors [Phase 2]
Phase 2 trial evaluating a combination of vaccine therapy and a biological therapy in adults with metastatic solid tumors; the study include…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a vaccine therapy for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating a melanoma vaccine with or without interleukin-2 in patients with metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]
Clinical trial update on vaccine therapy with or without interleukin-2 for metastatic melanoma, spanning Phase 1 and Phase 2, which has comp…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer [Phase 2]
Phase 2 study of denileukin diftitox in metastatic melanoma or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a monoclonal antibody therapy in combination with interleukin-2 for metastatic melanoma (including int…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a cancer vaccine with or without interleukin-2 for metastatic melanoma has completed enrollment and is r…